Operating Lease, Right-of-Use Asset in USD of Arbutus Biopharma Corp from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Arbutus Biopharma Corp quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • Arbutus Biopharma Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Arbutus Biopharma Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $0 -$1.14M -100% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $0 -$1.24M -100% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $0 -$1.33M -100% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $1.05M -$368K -26% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 $1.14M -$358K -23.8% 30 Sep 2024 10-Q 06 Nov 2024
Q2 2024 $1.24M -$348K -22% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $1.33M -$338K -20.3% 31 Mar 2024 10-Q 02 May 2024
Q4 2023 $1.42M -$328K -18.8% 31 Dec 2023 10-K 27 Mar 2025
Q3 2023 $1.5M -$319K -17.5% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $1.59M -$337K -17.5% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $1.67M -$342K -17% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $1.74M -$348K -16.6% 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $1.82M -$353K -16.2% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $1.92M -$303K -13.6% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $2.01M -$308K -13.3% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $2.09M -$313K -13% 31 Dec 2021 10-K 02 Mar 2023
Q3 2021 $2.17M -$317K -12.7% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $2.23M -$350K -13.6% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $2.32M -$342K -12.9% 31 Mar 2021 10-Q 05 May 2021
Q4 2020 $2.41M -$333K -12.2% 31 Dec 2020 10-K 03 Mar 2022
Q3 2020 $2.49M -$326K -11.6% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $2.58M -$326K -11.2% 30 Jun 2020 10-Q 07 Aug 2020
Q1 2020 $2.66M -$424K -13.8% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $2.74M +$2.74M 31 Dec 2019 10-K 04 Mar 2021
Q3 2019 $2.82M 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $2.9M 30 Jun 2019 10-Q 05 Aug 2019
Q1 2019 $3.08M 31 Mar 2019 10-Q 06 May 2019
Q4 2018 $0 31 Dec 2018 10-K 05 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.